KEAP1 and cancer: Numerous studies have shown that the Keap1 decrease in variety of cancers, including breast, ovarian, liver, non-small cell lung, colorectal, liver, gallbladder, head and neck squamous cell carcinoma [[45], [46], [47], [48], [49]].